The Cooper Companies, Inc. (NASDAQ:COO) Receives Average Rating of “Moderate Buy” from Analysts

Shares of The Cooper Companies, Inc. (NASDAQ:COO) have been assigned an average recommendation of “Moderate Buy” from the sixteen analysts that are presently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, six have issued a hold rating, eight have given a buy rating and one has issued a strong buy rating on the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $90.7692.

A number of brokerages have recently issued reports on COO. Needham & Company LLC dropped their price target on shares of Cooper Companies from $100.00 to $99.00 and set a “buy” rating on the stock in a research note on Tuesday, February 3rd. KeyCorp reaffirmed a “sector weight” rating on shares of Cooper Companies in a report on Friday, December 5th. JPMorgan Chase & Co. increased their target price on Cooper Companies from $66.00 to $78.00 and gave the stock a “neutral” rating in a research note on Friday, December 5th. Barclays set a $98.00 price target on Cooper Companies and gave the company an “overweight” rating in a report on Monday, January 26th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $94.00 price objective (up previously from $83.00) on shares of Cooper Companies in a report on Friday, December 5th.

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $81.70 on Friday. The stock has a fifty day moving average price of $81.80 and a 200 day moving average price of $74.75. Cooper Companies has a 1-year low of $61.78 and a 1-year high of $94.17. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.89 and a quick ratio of 1.13. The company has a market cap of $16.01 billion, a PE ratio of 43.46, a P/E/G ratio of 2.37 and a beta of 1.03.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, December 4th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.04. Cooper Companies had a net margin of 9.16% and a return on equity of 10.02%. The company had revenue of $1.07 billion for the quarter, compared to analysts’ expectations of $1.06 billion. During the same period in the previous year, the company posted $1.04 EPS. Cooper Companies’s revenue was up 4.6% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Sell-side analysts forecast that Cooper Companies will post 3.98 EPS for the current year.

Insider Buying and Selling at Cooper Companies

In related news, Director Lawrence Erik Kurzius bought 2,000 shares of the stock in a transaction on Wednesday, December 17th. The shares were bought at an average cost of $82.50 per share, for a total transaction of $165,000.00. Following the completion of the transaction, the director owned 7,777 shares of the company’s stock, valued at $641,602.50. This represents a 34.62% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Holly R. Sheffield bought 1,230 shares of the company’s stock in a transaction on Tuesday, December 16th. The stock was bought at an average cost of $80.75 per share, with a total value of $99,322.50. Following the completion of the acquisition, the insider owned 39,052 shares of the company’s stock, valued at $3,153,449. This represents a 3.25% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last 90 days, insiders acquired 16,014 shares of company stock worth $1,304,416. Company insiders own 1.98% of the company’s stock.

Institutional Investors Weigh In On Cooper Companies

A number of institutional investors and hedge funds have recently modified their holdings of the company. Root Financial Partners LLC raised its holdings in Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after purchasing an additional 162 shares during the last quarter. Bell Investment Advisors Inc raised its stake in shares of Cooper Companies by 106.3% during the 3rd quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after buying an additional 219 shares during the last quarter. CYBER HORNET ETFs LLC purchased a new stake in shares of Cooper Companies in the 2nd quarter worth about $36,000. True Wealth Design LLC boosted its position in shares of Cooper Companies by 484.8% in the 4th quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after buying an additional 383 shares in the last quarter. Finally, Cromwell Holdings LLC grew its stake in Cooper Companies by 128.8% in the 4th quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock valued at $40,000 after acquiring an additional 273 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.